Development and validation of the Methotrexate Experience Questionnaire, a new methotrexate oral treatment adherence tool in rheumatoid arthritis.

Jeffrey R CurtisJan Michael NebeskyElodie de BockChristine de la LogeBenoit ArnouldRobert DaveyJenny DevenportAttila Pethö-Schramm

Published in: Journal of patient-reported outcomes (2021)

The 24-item MEQ is a reliable and valid instrument to assess the adherence of RA patients taking MTX, potentially improving over historical refill rate metrics by providing insights into the individual reasons for lack of adherence. This information should facilitate clinician-patient discussions and help inform treatment decisions.

Keyphrases

rheumatoid arthritis
high dose
newly diagnosed
end stage renal disease
disease activity
ejection fraction
healthcare
type diabetes
cross sectional
interstitial lung disease
metabolic syndrome
ankylosing spondylitis
patient reported outcomes
adipose tissue
health information
social media